ADC Therapeutics (ADCT) Earnings Analysis
ADC Therapeutics (ADCT) has no confirmed upcoming earnings date. Last quarter (2026-05-04) it missed with EPS -0.21 USD vs -0.19 USD est (-10.5%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -1.18.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ADCT next report earnings?
No confirmed upcoming earnings date is currently scheduled for ADCT. This page updates as the calendar is published.
ADCT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-04 | -0.21 USD | -0.19 USD | -10.5% | Miss |
| 2026-03-10 | -0.04 USD | -0.32 USD | +87.5% | Beat |
| 2025-11-10 | -0.3 USD | -0.4 USD | +25% | Beat |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
ADCT valuation and analyst view
| Trailing P/E | -1.18 |
|---|---|
| Trailing EPS | -0.88872 USD |
| Price / book | -0.88 |
| Dividend yield | 0.00% |
| Market cap | 0.15B |
| Analyst consensus | Hold (5 buy / 6 hold / 1 sell) |
| Avg price target | 3.5 USD |
Related research pages
Frequently asked questions
When is ADC Therapeutics (ADCT)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ADCT. This page updates as the calendar is published.
Did ADCT beat earnings last quarter?
In its 2026-05-04 report, ADCT posted EPS of -0.21 USD versus a -0.19 USD estimate — a miss of 10.5%.
What is ADCT's earnings track record?
Over the last 3 reported quarters with consensus data, ADCT beat estimates 2 times (67%).
What is ADCT's current P/E ratio and EPS?
ADCT trades at a trailing P/E of -1.18 on trailing EPS of -0.8887174917610409 USD.
What do analysts rate ADCT?
Analyst consensus is "Hold" across 12 ratings (0 strong buy, 5 buy, 6 hold, 1 sell, 0 strong sell). Average 12-month price target: 3.5 USD.